Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ chain and CR3 (CD11b/CD18)

被引:117
|
作者
van Egmond, M
van Vuuren, AJH
Morton, HC
van Spriel, AB
Shen, L
Hofhuis, FMA
Saito, T
Mayadas, TN
Verbeek, JS
van de Winkel, JGJ
机构
[1] Univ Utrecht, Med Ctr, Dept Immunol, Immunotherapy Lab, NL-3584 EA Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Medarex Europe, Utrecht, Netherlands
[3] Univ Oslo, Dept Immunohistochem & Immunopathol, Oslo, Norway
[4] Dartmouth Med Sch, Dept Immunol & Microbiol, Lebanon, NH USA
[5] Chiba Univ, Grad Sch Med, Dept Mol Genet, Chiba, Japan
[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V93.12.4387.412k08_4387_4394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Even though more immunoglobulin A (IgA) is produced in humans than all other isotypes combined, relatively little is known about receptors that bind the Fc part of IgA. The myeloid IgA receptor, Fc alpha RI (CD89), triggers various effector functions in vitro, but its in vivo role remains unclear. Here, a transgenic mouse model is described in which Fc alpha RI is expressed under its own regulatory sequences, Receptor expression and regulation by cytokines was comparable to the human situation and hFc alpha RI can trigger phagocytosis and lysis of tumor cells, To analyze the contribution of the FcR gamma chain or the beta 2 integrin CR3 (CD11b/CD18) in Fc alpha RI biological function, Fc alpha RI transgenic mice were crossed with either FcR gamma chain -/- or CR3 -/- mice. In contrast to in vitro data, FcR gamma chain was essential for surface expression of hFc alpha RI in vivo, Functional studies in hFc alpha RI/gamma-/-mice were, therefore, limited. In vitro studies showed FcR gamma chain to be necessary for phagocytosis. Neither hFc alpha RI expression nor phagocytosis, triggered via hFc alpha RI, were influenced by CR3. Remarkably, the capacity to lyse tumor targets was ablated in hFc alpha RI transgenic/CR3-/- mice, although binding of neutrophils to tumor cells was intact. This shows a previously unrecognized importance of CR3 for hFc alpha RI-mediated antibody-dependent cellular cytotoxicity (ADCC). (C) 1999 by The American Society of Hematology.
引用
收藏
页码:4387 / 4394
页数:8
相关论文
共 50 条
  • [31] INVESTIGATION OF THE COMPLEMENT RECEPTOR-3 (CD11B/CD18) IN HUMAN RECTAL EPITHELIUM
    HUSSAIN, LA
    KELLY, CG
    RODIN, A
    JOURDAN, M
    LEHNER, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 102 (02): : 384 - 388
  • [32] Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion
    Gordon D. Ross
    Immunologic Research, 2002, 25 : 219 - 227
  • [33] Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion
    Ross, GD
    IMMUNOLOGIC RESEARCH, 2002, 25 (03) : 219 - 227
  • [34] CRYSTAL-STRUCTURE OF THE A-DOMAIN FROM THE A-SUBUNIT OF INTEGRIN CR3 (CD11B/CD18)
    LEE, JO
    RIEU, P
    ARNAOUT, MA
    LIDDINGTON, R
    CELL, 1995, 80 (04) : 631 - 638
  • [35] Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles
    Sutterwala, FS
    Rosenthal, LA
    Mosser, DM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (06) : 883 - 890
  • [36] A new function of CD11b/CD18: Complement Receptor 3 (CR3) is critical in late defense against intracellular Chlamydia psittaci in mouse lung infection
    Dutow, Pavel
    Fehlhaber, Beate
    Laudeley, Robert
    Bothe, Miriam
    Rheinheimer, Claudia
    Glage, Silke
    Klos, Andreas
    MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 263 - 263
  • [37] INVOLVEMENT OF CD11B/CD18 IN ENHANCED NEUTROPHIL ADHESION BY FC-GAMMA RECEPTOR STIMULATION
    KUSUNOKI, T
    TSURUTA, S
    HIGASHI, H
    HOSOI, S
    HATA, D
    SUGIE, K
    MAYUMI, M
    MIKAWA, H
    JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (06) : 735 - 742
  • [38] CYTOPLASMIC TAILS OF HUMAN-COMPLEMENT RECEPTOR TYPE-3 (CR3, CD11B CD18) REGULATE LIGAND AVIDITY AND THE INTERNALIZATION OF OCCUPIED RECEPTORS
    RABB, H
    MICHISHITA, M
    SHARMA, CP
    BROWN, D
    ARNAOUT, MA
    JOURNAL OF IMMUNOLOGY, 1993, 151 (02): : 990 - 1002
  • [39] Complement receptor 3 (CD11b/CD18) is implicated in the elimination of β-amyloid peptides
    Choucair-Jaafar, Nada
    Laporte, Vincent
    Levy, Rachel
    Poindron, Philippe
    Lombard, Yves
    Gies, Jean-Pierre
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (01) : 115 - 122
  • [40] A mixed population of immature and mature leucocytes in umbilical cord blood results in a reduced expression and function of CR3 (CD11b/CD18)
    Reddy, RK
    Xia, Y
    Hanikyrová, M
    Ross, GD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 114 (03): : 462 - 467